Occurrence of CIP/CIM ‐ in screened population · critically ill patients
Corticosteroids showed no clear difference in occurrence of CIP/CIM ‐ in screened population compared with placebo compared (moderate certainty).
1 finding from 1 review
Change in 9‐hole peg test (HPT) at 12 months (seconds) · people with fatigue in peripheral neuropathy
1 finding from 1 review
Serious adverse events · people with fatigue in peripheral neuropathy
Ascorbic acid showed no clear difference in serious adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Serious adverse events · people with fatigue in Guillain‐Barré syndrome
1 finding from 1 review
no estimate extracted
80 participants
GRADE not reported
Change in activity limitations · people with fatigue in peripheral neuropathy
1 finding from 1 review
Short‐term overall improvement (three months or less) · People with carpal tunnel syndrome on a waiting list for carpal tunnel release
It is very uncertain whether neurodynamic mobilisation changes short‐term overall improvement (three months or less) compared with no treatment (very low certainty).
1 finding from 1 review
Adverse effects · People with carpal tunnel syndrome on a waiting list for carpal tunnel release
1 finding from 1 review
Short‐term improvement in CTS symptoms (pain) (3 months or less) ‐ At end of 12 weeks treatment (Protouch Keyboard) Scale: 0 to 10 · People with carpal tunnel syndrome on a waiting list for carpal tunnel release
1 finding from 1 review
Short‐term improvement in functional ability or health‐related quality of life (hand function) (three months or less) · People with carpal tunnel syndrome on a waiting list for carpal tunnel release
It is very uncertain whether neurodynamic mobilisation changes short‐term improvement in functional ability or health‐related… compared with no treatment (very low certainty).
1 finding from 1 review
Improvement in neurophysiological parameters at ≤ 3 months · People with carpal tunnel syndrome on a waiting list for carpal tunnel release
1 finding from 1 review
CTS symptoms (Boston CTS questionnaire) ‐ long‐term improvement: > 3 monthsScale: 1 to 5, higher is worse · People with carpal tunnel syndrome on a waiting list for carpal tunnel release
1 finding from 1 review
Long‐term improvement in functional ability or health‐related quality of life (more than three months) · People with carpal tunnel syndrome on a waiting list for carpal tunnel release
1 finding from 1 review
Need for surgery · People with carpal tunnel syndrome on a waiting list for carpal tunnel release
It is very uncertain whether neurodynamic mobilisation changes need for surgery compared with no treatment (very low certainty).
1 finding from 1 review
Change in ankle dorsiflexion range of motion Lidcome Template in degrees. Scale from: 0.36 to 31.28. · patients with patients with reduced ankle range of motion in neuromuscular disease
1 finding from 1 review